Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MediWound Ltd. - Ordinary Shares (NQ:MDWD)

17.27 +0.02 (+0.12%)
Streaming Delayed Price Updated: 12:42 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MediWound Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Expands Global Presence as NexoBrid® Gains Approval in India
Exclusive marketing and distribution agreement signed with Bharat Serum and Vaccines Limited (BSV), a leading biopharmaceutical company 
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces a 1-for-7 Reverse Share Split
From MediWound Ltd.
Via GlobeNewswire
News headline image
Recap: MediWound Q2 Earnings ↗
  MediWound (NASDAQ:MDWD) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
MediWound Posts Early Data From Non-Melanoma Skin Cancer Trial ↗
 
Via Benzinga
News headline image
MediWound's EscharEx Shows Safe, Effective, Rapid Debridement Of Leg Ulcers ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 15, 2022 ↗
Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million. 
Via Benzinga
News headline image
MediWound to Report Third Quarter 2022 Financial Results
Conference Call and Webcast Scheduled for Tuesday, November 15, 2022 at 8:30 am Eastern Time 
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound: Q1 Earnings Insights ↗
MediWound (NASDAQ:MDWD) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
MediWound: Q4 Earnings Insights ↗
MediWound (NASDAQ:MDWD) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
MediWound Earnings Preview ↗
MediWound (NASDAQ:MDWD) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
News headline image
MediWound Announces Formation of Strategic Advisory Board
Esteemed group of industry leaders to contribute expertise and experience to MediWound’s strategic and operational activities 
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound's EscharEx® Featured in Oral and Poster Presentations at the Symposium on Advanced Wound Care (SAWC) Fall 2022
EscharEx’s promising results from the completed Phase 2 trials were highlighted 
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces Closing of the Concurrent Registered Direct and Private Placement Offerings
Gross Proceeds of $30.5 Million Raised 
From MediWound Ltd.
Via GlobeNewswire
News headline image
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Dow Turns Higher; Crude Oil Rises 0.7% ↗
U.S. stocks pared some losses, with the Dow Jones turning higher toward the end of trading on Thursday. 
Via Benzinga
News headline image
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session ↗
 Gainers 
Via Benzinga
News headline image
Nasdaq Drops Over 100 Points; Spero Therapeutics Shares Spike Higher ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Thursday. 
Via Benzinga
News headline image
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
FDA Accepts MediWound's Refiling For Severe Thermal Burns Therapy For Review ↗
The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ: MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Earnings Scheduled For May 17, 2022 ↗
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is likely to report earnings for its first quarter. 
Via Benzinga
News headline image
Preview: MediWound's Earnings ↗
MediWound (NASDAQ:MDWD) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that MediWound will... 
Via Benzinga
News headline image
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More ↗
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
MediWound Posts Promising EscharEx Data For Chronic Wounds ↗
MediWound Ltd (NASDAQ: MDWD) has announced results from its U.S. Phase 2 clinical study of EscharEx for the debridement of venous leg ulcers (VLUs). 
Via Benzinga
News headline image
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
36 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 46% to $21.13 after jumping around 35% on Wednesday. Eos Energy Enterprises, Inc. (NASDAQ: EOSE... 
Via Benzinga
News headline image
Earnings Scheduled For March 17, 2022 ↗
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... 
Via Benzinga
News headline image
63 Biggest Movers From Yesterday ↗
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 39.3% to close at $20.20 on Thursday after jumping around 35% on Wednesday. DBV Technologies S.A. (... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.